Forecast: Obstructive Airway Diseases Medicine Use in France

The forecasted use of medicines for obstructive airway diseases in France from 2024 to 2028 remains stable at 68.9 units, as indicated by the defined daily dosage per thousand persons per day. This consistency reflects a zero percent year-on-year variation, suggesting a steady consumption pattern over the five-year period. The absence of fluctuations indicates that changes in the prevalence or treatment patterns of obstructive airway diseases are not anticipated in the immediate future.

Future trends to watch for:

• Potential advancements in healthcare technology could introduce new medication options or treatment protocols, impacting drug usage.
• Public health initiatives aimed at reducing smoking rates and improving air quality may influence the prevalence of obstructive airway diseases.
• Population demographics shifts, particularly an aging population, could alter the demand for these medications.